MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space

Yanru Qu, Keyue Qiu, Yuxuan Song, Jingjing Gong, Jiawei Han, Mingyue Zheng, Hao Zhou, Wei-Ying Ma
Proceedings of the 41st International Conference on Machine Learning, PMLR 235:41749-41768, 2024.

Abstract

Generative models for structure-based drug design (SBDD) have shown promising results in recent years. Existing works mainly focus on how to generate molecules with higher binding affinity, ignoring the feasibility prerequisites for generated 3D poses and resulting in false positives. We conduct thorough studies on key factors of ill-conformational problems when applying autoregressive methods and diffusion to SBDD, including mode collapse and hybrid continuous-discrete space. In this paper, we introduce MolCRAFT, the first SBDD model that operates in the continuous parameter space, together with a novel noise reduced sampling strategy. Empirical results show that our model consistently achieves superior performance in binding affinity with more stable 3D structure, demonstrating our ability to accurately model interatomic interactions. To our best knowledge, MolCRAFT is the first to achieve reference-level Vina Scores (-6.59 kcal/mol) with comparable molecular size, outperforming other strong baselines by a wide margin (-0.84 kcal/mol). Code is available at https://github.com/AlgoMole/MolCRAFT.

Cite this Paper

BibTeX
@InProceedings{pmlr-v235-qu24a, title = {{M}ol{CRAFT}: Structure-Based Drug Design in Continuous Parameter Space}, author = {Qu, Yanru and Qiu, Keyue and Song, Yuxuan and Gong, Jingjing and Han, Jiawei and Zheng, Mingyue and Zhou, Hao and Ma, Wei-Ying}, booktitle = {Proceedings of the 41st International Conference on Machine Learning}, pages = {41749--41768}, year = {2024}, editor = {Salakhutdinov, Ruslan and Kolter, Zico and Heller, Katherine and Weller, Adrian and Oliver, Nuria and Scarlett, Jonathan and Berkenkamp, Felix}, volume = {235}, series = {Proceedings of Machine Learning Research}, month = {21--27 Jul}, publisher = {PMLR}, pdf = {https://raw.githubusercontent.com/mlresearch/v235/main/assets/qu24a/qu24a.pdf}, url = {https://proceedings.mlr.press/v235/qu24a.html}, abstract = {Generative models for structure-based drug design (SBDD) have shown promising results in recent years. Existing works mainly focus on how to generate molecules with higher binding affinity, ignoring the feasibility prerequisites for generated 3D poses and resulting in false positives. We conduct thorough studies on key factors of ill-conformational problems when applying autoregressive methods and diffusion to SBDD, including mode collapse and hybrid continuous-discrete space. In this paper, we introduce MolCRAFT, the first SBDD model that operates in the continuous parameter space, together with a novel noise reduced sampling strategy. Empirical results show that our model consistently achieves superior performance in binding affinity with more stable 3D structure, demonstrating our ability to accurately model interatomic interactions. To our best knowledge, MolCRAFT is the first to achieve reference-level Vina Scores (-6.59 kcal/mol) with comparable molecular size, outperforming other strong baselines by a wide margin (-0.84 kcal/mol). Code is available at https://github.com/AlgoMole/MolCRAFT.} }
Endnote
%0 Conference Paper %T MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space %A Yanru Qu %A Keyue Qiu %A Yuxuan Song %A Jingjing Gong %A Jiawei Han %A Mingyue Zheng %A Hao Zhou %A Wei-Ying Ma %B Proceedings of the 41st International Conference on Machine Learning %C Proceedings of Machine Learning Research %D 2024 %E Ruslan Salakhutdinov %E Zico Kolter %E Katherine Heller %E Adrian Weller %E Nuria Oliver %E Jonathan Scarlett %E Felix Berkenkamp %F pmlr-v235-qu24a %I PMLR %P 41749--41768 %U https://proceedings.mlr.press/v235/qu24a.html %V 235 %X Generative models for structure-based drug design (SBDD) have shown promising results in recent years. Existing works mainly focus on how to generate molecules with higher binding affinity, ignoring the feasibility prerequisites for generated 3D poses and resulting in false positives. We conduct thorough studies on key factors of ill-conformational problems when applying autoregressive methods and diffusion to SBDD, including mode collapse and hybrid continuous-discrete space. In this paper, we introduce MolCRAFT, the first SBDD model that operates in the continuous parameter space, together with a novel noise reduced sampling strategy. Empirical results show that our model consistently achieves superior performance in binding affinity with more stable 3D structure, demonstrating our ability to accurately model interatomic interactions. To our best knowledge, MolCRAFT is the first to achieve reference-level Vina Scores (-6.59 kcal/mol) with comparable molecular size, outperforming other strong baselines by a wide margin (-0.84 kcal/mol). Code is available at https://github.com/AlgoMole/MolCRAFT.
APA
Qu, Y., Qiu, K., Song, Y., Gong, J., Han, J., Zheng, M., Zhou, H. & Ma, W.. (2024). MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space. Proceedings of the 41st International Conference on Machine Learning, in Proceedings of Machine Learning Research 235:41749-41768 Available from https://proceedings.mlr.press/v235/qu24a.html.

Related Material